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A simulation study on transcellular fluid shifts induced by hemodialy-
sis. A computer-based model has been developed to predict the changes
in serum sodium, urea concentration, and osmolality as well as transcel-
lular fluid distribution which occur during hemodialysis. Sodium and
urea transfers across the dialyzer membrane and transcellular fluid
shifts in response to the sodium transfer were modeled assuming that
only sodium and its accompanying anions are important as effective
osmotic substances in extracellular fluid. Model predictions were
consistent with values measured in five patients who were studied on
hemodialysis at three different dialysate sodium concentrations equal to
7% below and 7% above the predialysis serum concentration. The
measurements and model predictions indicate that serum sodium con-
centration decreases and intracellular fluid volume increases in dialyses
with dialysate Na concentration used in conventional hemodialysis,
whereas serum sodium concentration increases and intracellular vol-
ume decreases in high sodium dialyses. An analysis of model predic-
tions indicates that a reasonable estimation of total body water and the
intracellular to extracellular volume ratio enables us to accurately
predict the magnitude of transcellular fluid shifts induced by hemodialy-
sis as well as the postdialysis serum sodium concentration and
osmolality.
Une étude en simulation des transferts transcellulaires de fluides induits
par l'hemodialyse. Un modèle assisté par ordinateur a été développé
pour prCdire les modifications du sodium, de Ia concentration uréique,
et de l'osmolalité sérique, et de Ia distribution transcellulaire de fluides
qui surviennent pendant l'hémodialyse. Les transferts de sodium et
d'urée a travers Ia membrane du dialyseur et les deplacements transcel-
lulaires de fluides en réponse au transfert de sodium ont Cté modélisés
en supposant que seul le sodium et ses anions accompagnateurs sont
importants en tant que substances osmotiquement efficaces dans le
fluide extracellulaire. Les predictions du modèle étaient en accord avec
les valeurs mesurées chez cinq malades qui ont eté étudiés en hémodia-
lyse avec trois différentes concentrations du sodium dans le dialysat,
Cgale, 7% inférieure ou 7% supérieure a Ia concentration serique avant
dialyse. Les mesures et les predictions du modCle indiquent que Ia
concentration de sodium sérique diminue et que le volume de fluide
intracellulaire augmente lors des dialyses avec Ia concentration de Na
dans Ic dialysat utilisée dans l'hemodialyse conventionnelle, tandis que
Ia concentration de sodium serique augmente et que Ic volume intracel-
lulaire diminue lors des dialyses avec sodium élevé. Une analyse des
predictions du modèle indique qu'une estimation raissonable de l'eau
totale de l'organisme et du rapport du volume intracellulaire sur Ic
volume extracellulaire nous permet de prévoir de facon precise l'impor-
Lance des transferts transcellulaires de fluides induits par l'hémodia-
lyse, ainsi que Ia concentration de sodium et l'osmolalité sériques
postdialytiques.
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It has been demonstrated that the use of dialysate with a high
Na concentration reduces the incidence of hypotension [1],
disequilibrium syndrome [1, 2], and muscle cramps [1, 3] during
hemodialysis. The reasons for this reduction in symptoms are
not well understood, but may be related to differences in body
fluid distribution between the intracellular and extracellular
fluid compartments [1—4]. In the present study, measured
intracellular and extracellular fluid volumes as well as serum
Na concentration and osmolality before and after hemodial-
syis at three different dialysate Na concentrations were com-
pared to values predicted by a computerized model that simu-
lates transcellular fluid shifts during hemodialysis related to the
sodium transfer across the dialyzer membrane. The model
predictions were found to agree very well with the measured
values. The measurements and model predictions show that
high Na hemodialysis allows fluid removal from both the
intracellular and extracellular fluid compartments, whereas
with the Na concentration used in conventional hemodialysis,
fluid is removed from the extracellular compartment only.
Since the clinical validity of the model has been confirmed by
the agreement of the predictions with measured values of
postdialysis serum Na concentration and osmolality as well as
the magnitude of transcellular fluid shifts induced by hemodial-
ysis, the model permits a more complete quantitative analysis
of sodium and water metabolism in dialysis patients. By em-
ploying the principles described in the present study, it is
possible to utilize high Na dialysate without inducing long-
term positive sodium and fluid balance.
Methods
Applying a well established principle [51 governing trariscellu-
lar fluid dynamics to hemodialysis (HD) therapy, a computer-
based model [6] was developed to predict the changes in serum
[Na], blood urea nitrogen concentration (BUN), plasma osmo-
lality (Posm), and transcellular fluid distribution which occur
during HD. Only sodium and its accompanying anions were
considered important as effective osmotic substances in extra-
cellular fluid to induce transcellular fluid shifts, and urea was
assumed freely permeable across cell membranes. The detailed
formulations are described in the Appendix.
Five stable chronic HD patients (two males and three fe-
males; mean age, 49; range, 24 to 71 years) were studied. The
patients were admitted to the Clinical Research Center at the
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University of Missouri Hospital and Clinics, Columbia, Missou-
ri, in the evening prior to each study dialysis. Patients were
weighed upon admission, and if their weight was less than 2 kg
above their estimated ideal weight, they were given additional
fluids in the form of soup containing 100 mEq/liter of sodium.
Each patient underwent three study dialyses which differed
only in the sodium chloride concentration of the dialysate. The
patients were admitted separately for each of the three study
dialyses, and each study dialysis were separated by at least two
regular HD treatments. The order of study dialyses was ran-
domly determined. The dialysate sodium concentration was
adjusted on the basis of the predialysis serum [NaJ by adding
2.5 mEq/ml of sodium chloride to the basic dialysate. The
normal Na dialysate contained a dialysate Na concentration
equal to the patient's predialysis serum [Na] while the low
Na dialysate and high Na dialysate contained Na concen-
trations which were 7% less and 7% greater than the predialysis
serum [Naj, respectively. The basic dialysate contained 130
mEq/liter of Nat, 2 mEq/liter of K, 3.25 mEq/liter of Ca,
1.5 mEq/liter of 102 mEq/liter of Cr, 35 mEq/liter of
CH3COO and 200 mgldl of glucose. The dialysate flow rate
was always 500 mI/mm. Mean values of the extracorporeal
blood flow rate (QB), the hematocrit (Hct) and the dialyzer urea
clearance (Kurea) are listed in Table 1 for the three study groups.
Kurea was extrapolated from in vivo clearances measured on the
same types of dialyzers in other patients at a zero ultrafiltration
rate. Immediately prior to the dialysis treatment, serum [NaI,
BUN, and POsm were measured. Total body fluid volume (TBF)
and extracellular fluid volume (ECF) were also determined
before dialysis simultaneously using 3H20 and Na235SO4, re-
spectively [71. Patients were kept in a supine position until these
studies were completed. A 4-hr HD was then performed in a
bed with a metabolic scale. During the dialysis treatment, fluid
was removed at a constant rate of 0.5 kglhr, and serum [Nat]
was determined every hour. After the dialysis procedure, BUN,
POsm, and ECF were again determined, assuming that no
transcellular fluid shifts occurred following the dialysis proce-
dure. Postdialysis TBF was obtained assuming that changes in
TBF were equal to the changes in body weight. ICF was
calculated as the difference between TBF and ECF. It should be
noted that 200 to 700 ml of 0.9% (w/v) NaCl were infused in four
of five patients who developed symptomatic hypotension dur-
ing low Na HD. The detailed methods for body fluid volume
determination and their variability are described elsewhere [7,
8].
Results were expressed in terms of the mean SEM, and the
significance of the difference between pre- and postdialysis
values was tested by the Student's t test for paired samples.
This test was also used for comparing measured postdialysis
values with the model predictions.
Results
Validity of model assumptions
As described in detail in the Appendix, firstly, water is
assumed freely permeable to cell membranes. Therefore, effec-
tive osmolality should be equal in both intra- and extracellular
compartments across the cell membrane every moment.
C1(t) = CE(t)
Table 1. Conditions of dialysis for the three study groupsa
Group
Dialysate Na
mEqiliter
QB
mi/mm
Hct
%
Kurea
mi/mm
Normal Na HD 141 2 212 6 23.1 3.7 169 10
Low Na HD 131 1 215 6 23.5 2.9 171 10
HighNaHD 150±2 215±6 22.0±3.2 176±11
a Results are expressed as mean SEM (N = 5) in each group.
Table 2. Amount of intracellular effective osmotic cations before and
after hemodialysisa
Group Before HD Significance After HD
Normal Na HD 3860 320 NS 3820 330
Low Na HD 3750 350 NS 3660 320
High Na HD 3610 280 NS 3600 290
a Results are expressed as mean SEM (N = 5) in the unit of mEq in
each group. The significance of the difference is based on a paired t test.
Where C1(t) and CE(t) are the intra- and extracellular effective
osmolality at time t, respectively.
Secondly, we assumed that only sodium and its accompany-
ing anions are important as effective osmotic substances in the
extracellular compartment.
RDC(t) = k x [Na(t)] x (2)
where k, [Na(t)], RD, and F are the osmotic coefficient for
sodium chloride, serum sodium concentration at time t, the
Gibbs-Donnan ratio, and the correction factor for the exclusion
volume of plasma protein, respectively, and [Na(t)] X R/Fw
corresponds to the sodium concentration in the interstitial fluid.
Although sodium and urea are the major osmotic substances in
the extracellular fluid in uremic patients, only sodium and its
accompanying anions are considered important in osmotically
induced transcellular fluid shifts.
Thirdly, since the effective osmotic substances do not move
across the cell membrane, the absolute amount of effective
osmotic substances in the cell is assumed constant.
ICF(t) x C1(t) = ICF(t + t) x C1(t + t) (3)
where ICF(t) is the intracellular fluid volume at time t.
Solving equations (1) to (3), these assumptions are expressed
simply as follows:
ICF(t) x [Na(t)] = ICF(t + t) X [Na(t + st)] (4)
This equation is a well known principle [5] governing transcellu-
lar fluid distribution and means that the absolute amount of
intracellular effective osmotic cations is constant. Since we
measured the intracellular fluid volume and serum Na concen-
tration before and after hemodialysis, the validity of assump-
tions underlying our model can be directly confirmed in the
present experimental situations. As shown in Table 2, there was
no significant difference in the absolute amount of intracellular
effective osmotic cations between before and after hemodialysis
in any group, suggesting the validity of application of the well
(1) known principle [5] to hemodialysis therapy.
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Table 3. Serum Na concentrations and body fluid volumes before and after hemodia1ysis
Before HD After HD
Group Parameters Measured Significance Measured Significance
Model
prediction
Normal Na HD
Serum [Nat], mEqiliter
ICF, liters
ECF, liters
140 2
27.6 2.4
16.2 1.6
NS
NS
P < 0.02
138 I
27.8 2.5
14.0 1.2
NS
NS
NS
138
27.9
13.8
I
2.4
1.5
Low Na HD
Serum [Na], mEqiliter
ICF, liters
ECF, liters
139 1
27.0 2.5
15.8 1.4
P < 0.05
NS
P < 0.001
134 2
27.4 2.5
13.5 1.4
NS
P < 0.02
P < 0.02
132
28.4
12.5
1
2.6
1.5
High Na' HD
Serum [Na], inEqiliter
ICF, liters
ECF, liters
140 I
25.9 2.1
16.5 1.8
P < 0.02
NS
NS
145 2
24.9 2.0
15.8 1.6
NS
NS
NS
144
25.1
15.5
2
1.9
1.8
a Results are expressed as mean SEM (N = 5) in each group. The significance of differences is based on a paired t test.
Comparison of model predictions with experimental
measurements
Mean pre- and postdialysis values of serum [Nat] and body
fluid volumes that were experimentally measured, and the mean
postdialysis values predicted by the computer model are sum-
marized in Table 3 for the normal, low, and high dialysate Na
dialyses. For those patients with normal and high dialysate
Nat, the experimentally determined values of serum {Nai and
body fluid volumes are in excellent agreement with the model
predictions. For those patients with low dialysate Na, there is
no significant difference between the measured and predicted
serum [Na] values, but the measured and predicted values of
body fluid volumes are different at the P = 0.02 level of
significance. The model predicts an intracellular fluid shift
larger than experimentally measured.
Figure 1 is a plot of the time course of mean serum [NaJ
during dialysis with the normal, low and high dialysate Na
concentrations. The lines shown are computer-predicted, and
the plotted points are the measured values. There was an
excellent agreement between the measured and predicted val-
ues. The only significant difference was seen in the value at 1 hr
after the beginning of the high Na hemodialysis. Serum [Na}
levels are relatively unchanged with the normal dialysate Na
concentration, but increase significantly with the high Na
dialysate, and decrease significantly with the low Na dialy-
sate. With the normal dialysate Na concentration, there is
little change in intracellular volume, and the ultrafiltered fluid is
removed mainly from the extracellular compartment. With a
high Na dialysate concentration, the intracellular compart-
ment also contributes to the fluid removal, so that there is less
shrinkage of the extracellular fluid volume. With the low Na
dialysate concentration, not only does the extracellular fluid
volume shrink due to ultrafiltration, but in addition, there is an
intracellular fluid shift so that the intracellular compartment is
expanded by the dialysis procedure.
Measured and predicted BUN and POsm levels are compared
in Table 4. The predicted postdialysis values agree well with the
measured values. The fall in BUN levels pre- to postdialysis is
comparable in the three groups. The osmolality decrease is
smallest in the patients exhibiting high dialy sate Nat, expand-
ing with the normal Na dialysis, and being greatest in the low
Na dialysis. This is related to the direction of the change in
serum [Na] as shown in Table 3 and Figure 1.
Effects of sodium concentration gradient across the dialyzer
membrane
The change in serum sodium concentration (A[Na]) was
estimated based on our computer model as a function of the
sodium concentration gradient (DNa+) between dialysate and
serum (predialysis), and depicted in Figure 2A together with
measured values. There was no significant difference between
the estimated and measured values. The trend is linear with a
non-zero intercept on the X-axis. The non-zero X-intercept is
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Fig. 1. Serum [Na] as a function of time during hemodialysis. The
plotted points are the measured values (mean 5EM), and the solid line
is the computer prediction. The mean dialysate Na concentrations
used for each group are also plotted as a broken line. The significance of
the differences between measured and predicted serum [Nat] was
tested by the paired t test. The asterisk represents P < 0.005.
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Table 4. BUN and POm before and after hemodialysisa
Group Parameters
Before HD After HD
Measured Significance Measured Significance Model prediction
Normal Na HD BUN, mgldl
Posm, mOsmlkg H20
16
307
12
7
P < 0.02
P < 0.05
30 9
290 3
NS
NS
30
293
9
4
Low Na HD BUN, mgldl
P0, mOsmlkg H20
57
309
5
7
P < 0.001
P < 0.001
24 3
281 6
NS
NS
22
281
2
8
High Na HD BUN, mgldl
POSm, mOsmlkg H20
67
312
9
4
P < 0.001
P < 0.05
28 6
306 3
NS
NS
28
306
6
2
Results are expressed as mean SEM (N = 5) in each group. The significance of the differences is based on a paired t test.
equal to [Na(o)] x (RWFw— 1) where [Na(o)1 is the predialy-
sis serum sodium concentration in "molarity" (mEq/liter) mea-
sured by flamephotometer, RD is the Gibbs-Donnan ratio which
represents the influence of the negative charge of plasma
proteins on ion distribution between serum and dialysate, and
Fw is the correction factor for the exclusion volume of plasma
proteins. Due to the exclusion volume of plasma protein (Fw <
1) serum water Na concentration is [Na(o)]/Fw in "molar-
ity" (mEqlkg H20), and due to the Gibbs-Donnan effect (RD <
1) the dialysate Na concentration in diffusion equilibrium with
serum water across the dialyzer membrane is expressed as
[Na(o)] x R/F in both "molarity" and "molality." Al-
though both RD and F vary as functions of plasma total
protein concentration [9, 101, the ratio of RD/Fw is estimated
constant (1.03) over a wide range of total protein concentration
from 6.5 to 9.2 g/dl (see the Appendix). This figure is entered in
our computer program. The non-zero X-intercept indicates that
when serum and dialysate are in diffusion equilibrium, the
dialysate sodium is slightly (approximately 3%) higher than the
serum sodium expressed in "molarity." When the predialysis
serum [Na] is 140 mEq/liter, the dialysate Na concentration
of 144 mEq/liter is in diffusion equilibrium with the serum, and
the X-intercept is approximately 4 mEq/liter. For net sodium
transfer due to diffusion from dialysate to serum, the Nacon-
centration gradient between dialysate and predialysis serum
must exceed the value of the intercept. At gradients lower than
the value of the intercept, net sodium transfer from serum to
dialysate takes place, resulting in a decrease in serum [NaI as
observed in both normal and low Na hemodialyses.
Similarly, the influence of the sodium concentration gradient
(XDa+) between dialysate and serum (predialysis) on the
plasma osmolality change (LPosm) during dialysis is plotted in
Figure 2B. There was no significant difference between the
estimated and measured values. The trend is a linear one, the X-
axis intercept being related to the predialysis BUN. The posi-
tive intercept indicates such a sodium gradient that the sodium
transfer due to diffusion from dialysate to serum prevents the
change in POsm induced by the removal of urea.
The influence of the sodium gradient (DN5+) between
dialysate and the predialysis serum concentration on intracellu-
lar fluid volume is depicted in Figure 2C. Although there was a
significant difference (P < 0.02) in the patient with low dialysate
Na between the estimated and measured values (Table 3),
there was no significant difference in the total number of
patients. The trend is curvilinear, though the deviation from
linearity is small. The intercept on the X-axis is the same as in
Figure 2A. The intercept represents the sodium gradient be-
tween dialysate and serum required to prevent any changes in
intracellular volume, the change (ECF) in extracellular fluid
volume being equal to the amount of fluid removal by ultrafiltra-
tion. When higher dialysate Na concentrations beyond this
point are used, transcellular fluid shifts out of body cells are
predicted by the model, resulting in a change in ECF which
would be smaller than the net total body fluid loss. Similarly,
with the lower dialysate Na concentrations the transcellular
fluid shift will be into body cells, causing a greater decrease in
ECF than of total body fluid. As noted, measurements are
qualitatively the same as those predicted by the computer with
the use of lower dialysate sodium but failed to reach the same
magnitude.
Effects of body fluid volume
In these studies, the body fluid volumes were measured using
radioisotopes. As this is not feasible in routine clinical practice,
we estimated the influence of variations in body fluid volumes
on model predictions. The effects of both TBF and the ratio of
ICF/ECF on transcellular fluid shifts were negligibly small.
There were no effects in the ratio of ICF/ECF on serum [Na11
and POsm. Among initial body fluid volumes, therefore, only
TBF is important in determination of the postdialysis serum
[Na] and Pom. Even with a range of variation in total body
fluid volume as large as 10 liters, the deviations in the
postdialysis serum [Na] and POsm were as small as 1.5
mEq/liter and 4 mOsm/kgH2O, respectively. It is, therefore,
evident that a reasonable estimation of the total body water is
adequate for clinical application of the computer model, allow-
ing us to predict the postdialysis serum [Na] and OSm and the
approximate magnitude of transcellular fluid shifts under given
conditions of dialysis.
Discussion
Applying a well established principle [5] governing transcellu-
lar fluid dynamics to hemodialysis therapy, a computer-based
model [61 has been developed to predict the changes in serum
sodium, urea concentration, and osmolality as well as transcel-
lular fluid distribution which occur during hemodialysis. Al-
though we could not verify the validity of the principle in the
critical sense, the absolute amount of intracellular effective
osmotic cations was kept constant during hemodialysis (Table
2), confirming the clinical validity of application of the principle
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A High NaHD
• Normal NaHD
• Low NaHD
Fig. 2. Model prediction of the influence of dialysate Na concentra-
tion on serum [Nat] (A), plasma osmolality (B), and transcellular fluid
shifts (C). DNa+ represents the sodium concentration gradient be-
tween dialysate and predialysis serum. [Na], ZWosm, and ICF
represent the changes from pre- to postdialysis in serum Na concen-
tration, plasma osmolality, and intracellular fluid volume, respectively.
The plotted points are the measured values. There was no significant
difference between the predicted and measured values in any
parameter.
to hemodialysis therapy. Since the present studies were per-
formed in stable chronic hemodialysis patients, however, an
application of the principle to unstable or acute hemodialysis
patients must be examined further. There can be net flux with a
change in the absolute amount of intracellular effective osmotic
substances in severely ill patients (for example, severe hypoxia
and rapidly developing congestive heart failure) and in the
presence of certain pharmacologic agents.
The measurements and model predictions show that serum
[NaJ is decreased and intracellular fluid volume (ICF) is
increased during hemodialysis using dialysate Na concentra-
tions lower than those in diffusion equilibrium with predialysis
serum. On the other hand, serum [Na] is increased and ICF is
decreased during hemodialysis using dialysate Na concentra-
tions higher than those concentrations. The equilibrium dialy-
sate Na concentration is considered approximately 3% higher
than serum [NaJ expressed in "molarity" (mEq/liter), indicat-
ing that the dialysate Na concentration of 144 mEq/liter is in
diffusion equilibrium with the predialysis serum [Na] of 140
mEqlliter. Thus, serum [Nat] was decreased with the increase
in ICF when normal Na dialysate (141 2 mEq/liter) contain-
ing the same Na concentration as the predialysis serum [NaJ
or low Na dialysate (131 1 mEq/liter) containing 7% less
Na concentration than the predialysis serum [Naj was used,
while serum [Na] was increased with the decrease in ICF
when dialysate contained 7% higher Na concentration (150
2 mEq/liter) than the predialysis serum [Nat]. The postdialysis
values predicted by our model reasonably agree with the
measured values except for the changes in body fluid volumes
with low Na HD (Table 3). The measured extracellular to
intracellular fluid shifts induced by low Na HD were signifi-
cantly smaller than predicted. One possible explanation for this
is that four of the five patients had symptomatic hypotension
during low Na HD and received 200 to 700 ml of normal saline.
The infusion of normal saline would tend to reduce the fluid
shift into cells during low Na HD because of the higher Na
concentration in normal saline relative to that in the dialysate
used for low Na HD. However, the infusion can explain at
most only 0.3 liter of transcellular fluid shifts out of cells.
There are three other mechanisms not considered in our
model that could explain the discrepancy in the results with low
Na HD. During hemodialysis, because of fluid removal from
the vascular compartment, there is an increase in the hemato-
crit. This hemoconcentration may interfere with Na transport
across the dialyzer membrane due to a decrease in the extracor-
poreal plasma flow rate (see equation (11) in the Appendix). The
resulting decrease in Na dialysance would tend to reduce the
fluid shift into cells from the extracellular compartment. As a
consequence of vascular refilling and fluid movement into cells
the protein concentration increases and the hydrostatic pres-
sure decreases in the interstitium. These changes may have a
"braking" effect, in a sense, on the fluid shift into cells by
virtue of the resultant imbalance in Starling forces across the
cell membrane. Fairly large amounts of potassium, the major
intracellular osmotic substance, are removed during hemodialy-
sis [11, 121. The influence of such removal on transcellular fluid
shifts is not considered in the model. The loss of potassium out
of cells may decrease ICF due to the decrease in the intracellu-
lar effective osmolality. Therefore, potassium flux from the
intracellular to the extracellular compartment may also account
for the difference between the measured and predicted postdi-
alysis ICF, especially in low Na hemodialysis. In fact, the
absolute amount of intracellular effective osmotic cations did
decrease during hemodialysis, especially in the patient with low
Nat, although not significant statistically (Table 2).
Good agreement between model predictions and measured
values was also noted for the time trend of serum [NaJ (Fig. I),
and postdialysis values of BUN and POsm (Table 4). Hence,
these results substantiate the clinical validity of the model and
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the validity of the underlying assumptions. Having established
the clinical validity of the model, we have studied the influence
of initial body fluid volumes on the relationships between
dialysate Na concentration and serum [NaJ, Osm or trans-
cellular fluid shifts (Fig. 2). Total body fluid volume (TBF) and
the ratio of ICF/ECF were found to have a negligibly small
influence on transcellular fluid shifts. No influence of the ratio
of ICF/ECF on serum [Nai and POsm was noted. Only the
predialysis TBF was found to influence the postdialysis serum
[Nat] and POsm. When the TBF was altered by 10 liters, the
changes in serum [Na] and POsm were usually within 1.5
mEq/liter and 4 mOsm/kgH2O, respectively. Therefore, a rough
estimation of the predialysis TBF and the ICF/ECF ratio allows
us to predict with reasonable accuracy the postdialysis serum
[Na], BUN, POsm, and the change in intracellular volume.
Finally, the model will be useful in the planning of hemodialy-
sis therapy for individual patients when the target values for
serum [Na], Posm, and TBF will have been established, The
advantages of high Na hemodialysis over normal or low Na
hemodialysis in reducing the incidence of hypotension and
other symptoms have been reported [1—4]. However, high Na
hemodialysis is still not a part of routine clinical practice. A
possible reason for this could be the uncertainty in choosing the
optimal dialysate Na concentration. The Na concentration
should be high enough to reduce the incidence of hypotension
and other symptoms and yet not so high as to induce a positive
sodium and water balance, resulting in hypertension and pulmo-
nary edema. Using the model, we may be able to select the
highest dialysate Na concentration that results in a postdialy-
sis serum [Nat] within the normal range, thereby minimizing
the thirst induced by high Na HD. If the constancy of P0
during HD is considered important to prevent hypotension and
disequilibrium syndrome, the model can prescribe the desired
dialysate Na concentration to achieve this. By adjusting the
Na dialysance as well as the dialysate Na concentration, we
can keep the postdialysis serum [Nat] within the normal range
as well as hold POsm constant during the treatment. By analyz-
ing transcellular fluid shifts, we can calculate the extent to
which the extracellular volume is expanded by high Na HD
relative to normal Na or low Na HD. Such a calculation can
help us choose rates of fluid removal during the treatment to
prevent hypervolemia and the consequent hypertension and
pulmonary edema. The model, therefore, provides us with a
method for prescribing individualized hemodialysis therapy. By
achieving desired values for the postdialysis serum [Nat] and
for body fluid volume at each time of hemodialysis, sodium and
water balance can be maintained for a long time.
Appendix
Computer modeling of serum [Nat], body fluid volumes, and
plasma osmolality during hemodialysis
Our computerized model to predict the postdialysis serum
[Na] and body fluid volumes is based on the following
equations [6]. The first one represents the fluid mass balance
between intracellular and extracellular compartments.
ICF(t + M) + ECF(t + t)
= ICF(t) + ECF(t) — QF X Lt (1)
This equation basically states that the change in the combined
volume of intracellular (ICF) and extracellular (ECF) fluid
compartments from time t to t + t is equal to the net fluid
removal, where QF is the rate of ultrafiltration. The terms (t)
and (t + t) are used as the arguments of the functions, ICF and
ECF, and of other functions in later equations, and X (t) and X
(t + t) mean X at time t and t + t, respectively.
The second equation is the mass conservation relationship for
the sum total of effective osmotic substances in the cell which
do not penetrate the cell membrane.
ICF(t + t) x C1(t + t) = ICF(t) x C1(t) (2)
This equation states that the sum total of effective osmotic
substances in the cell is unchanged, changes in concentration
being related to fluid shifts across the cell membrane. Here,
C1(t) is the effective osmolality within the cell, and should be
equal to that in extracellular fluid, CE(t), because of osmotic
equilibrium across the cell membrane.
CL(t) = CE(t) (3)
The effective osmolalities, C1(t) and CE(t), are the quantitative
indices of the chemical potential of water, and this equation
means that the chemical potential of water is the same inside
every cell as it is in interstitial fluid. As the extracellular
effective osmolality changes, a transcellular fluid shift will
occur until the effective osmolality in both the extracellular and
intracellular compartments reaches equilibrium, resulting in a
change in the ICF.
The next equation is the mass balance relationship for the
sum total of effective osmotic substances in the extracellular
fluid.
ECF(t + t) x CE(t + t) — ECF(t) )< CE(t) =Dialysance
x t x {CD — CJ5(t)} — QF X t X CE(t) (4)
Here, Dialysance is defined as the minute rate of net exchange
by diffusion between blood and dialysate per unit dialysate —
blood concentration gradient, and CD is the effective osniolality
in the dialysate. Since it is assumed that these substances do not
enter the cell across the cell membrane, the equation indicates
that the changes in ECF of these substances reflects net
exchange by diffusion and removal by ultrafiltration. Dialy-
sance x t x {CD — CE(t)} represents net exchange of effective
osmotic substance between dialysate and extracellular fluid by
diffusion during the time interval between t and (t + st), and
—QF X 1t X CE(t) is net exchange by way of ultrafiltration,
where the + direction represents gain by the extracellular fluid.
In the above modeling, only Na and its accompanying
anions are considered important as effective osmotic sub-
stances in extracellular fluid, the cell membrane being assumed
to be freely permeable to urea. Therefore, there is a relationship
between effective osmolarity, CE(t), in extracellular fluid and
serum [Na(t)].
CE(t) = k )< [Na(t)] x F (5)
where k is the osmotic coefficient for sodium chloride that
converts concentration to osmolality, RD is the Gibbs-Donnan
ratio for Na, and F is the plasma water fraction, This
equation is an expression of total density of solute affecting the
colligative properties of the aqueous solution, in terms of the
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measured concentration of Na in serum. It corrects for serum The osmotic coefficient k referred to earlier was assumed to be
water fraction, for the Gibbs-Donnan equilibrium ratio, and for 1.9 for sodium chloride.
the activity coefficient of sodium chloride. The sodium concen- Solving equations (1) to (6), (9) and (11), [Na (t + At)], ICF(t
tration in interstitial fluid, [Na(t)] X RIFw also corresponds + At), and ECF(t + At) can be expressed in terms of [Na(t)],
to the dialysate Na concentration when serum and dialysate ICF(t), and ECF(t). If the initial conditions, [Na(o)J, ICF(o)
are in diffusion equilibrium across the dialyzer membrane. and ECF(o), are known, [Na(At)], ICF(At), and ECF(At) can
Similarly, there is a relationship between effective osmolality, be calculated. Repeating this process in steps of At using a
CD, in the dialysate and dialysate Na concentration, [Na]D. computer (9845S, Hewlett-Packard, Elkhart, Indiana),
+ [Na(t)], ICF(t), and ECF(t) at finitely spaced points in timeC = k x [Na ID (6) during hemodialysis are obtained, Similarly, BUN(t) and
Since k appears on both sides of equations (2) and (4) after Posrn(t) can then be calculated using equations (10), (12), and
substituting C1(t) and CE(t) by equation (5) and CD by equation (13). These parameters were calculated at intervals of I mm (At
(6), it factors out. Although both RD and Fw vary as functions of = 1), but no differences were seen with At in a range of 0.1 to
total protein concentration, T (gIdl), in plasma [9, 10], the ratio 5.0 mm.
of RD/Fw is estimated constant (1.03) over a wide range of total
protein concentrations from 6.5 to 9.2 g/dl.
RD = 1.004 x EXP (—0.008 x T)
F = I — 0.0107 X T
RD/Fw = 1.03 (6.5 T 9.2) (9)
In addition to modeling serum [Nat] and body fluid volume,
changes in blood urea nitrogen concentration (BUN) during
hemodialysis were also modeled. As urea is assumed to move
freely across the cell membrane and to be distributed uniformly
within total body water, the mass conservation relationship for
urea yields:
TBF(t x At) < BUN(t + At) — TBF(t) x BUN(t)
Fw Fw
BUN(t)
= GU x At — (Clearance + QF) x At x Fw
where TBF is the total body fluid voume, GU is the urea
nitrogen generation rate (assumed to be 7 mg/mm for stable
patients), and Fw is the plasma water fraction which was
assumed to be 0.925. The Na dialysance and urea clearance
were corrected for the influence of ultrafiltration on the plasma
or blood flow rates within the dialyzer as follows [13]:
Na dialysance Kurea x (1 —
QP
I QFUrea clearance = Kurea x I 1 — —
QB
Where the Na dialysance was assumed equal to the urea
clearance when QF = 0, Kurea is the dialyzer urea clearance
measured at a zero ultrafiltration rate, and Qp is the extracor-
poreal plasma flow rate calculated as QB x (1— Hct/l00).
The change in plasma osmolality (Posm) during hemodialysis
was calculated assuming that it occurs due to the changes in
serum [Nat] and BUN.
Posm(t + At) — Posm(t) = j— x {[Na(t + At)] —
[Na(t)]} + 1 {BUN(t + At) — BUN(t)} (13)2.8 X Fw
